Madrigal grants inducement equity awards to 27 new hires, including 2,754 stock options priced at USD 538.71
MDGL•Inducement equity awards to new hires
Madrigal Pharmaceuticals granted inducement equity awards to 27 new non-executive employees under its 2025 Inducement Plan.
Awards cover options for 2,754 shares priced at USD 538.71, based on the Sept. 1 closing price.
Options vest 25% on the first anniversary, then 6.25% each quarter thereafter, subject to continued employment.
The company also issued 16,149 time-based restricted stock units, vesting in four equal annual installments.
